Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1210 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-15

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed to provide long term clinical and virologic follow up in subjects infected with hepatitis C virus (HCV) who received interferon-based therapy or direct-acting antiviral agents (DAAs)-based therapy. This long term follow up study is observational and no treatment is provided for HCV infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C

NCT04301882

Chronic Hepatitis C

UNKNOWN

Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C

NCT04071353

Chronic Hepatitis C

UNKNOWN

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

NCT02583685

Chronic Hepatitis C Infection

COMPLETED PHASE2

Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)

NCT01760148

Hepatitis C, Chronic Liver Diseases Interferon Deficiency

UNKNOWN

Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

NCT01995266

Hepatitis C

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Hepatitis C Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with chronic hepatitis C treated with interferon-based therapy or direct-acting agents (DAAs)-based regimen;
* Provide written, informed consent;
* Be willing and able to comply with the visit schedule and protocol-mandated procedures.

Exclusion Criteria

* Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up time frame;
* History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol.
* Inability to provide written informed consent.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No